Meeting the challenge of viral vector manufacture
Interviewee/Contributor
Gabriel Festoc
Organisation
Polyplus-Transfection SA
Gene therapy
Human gene therapy - immunogenicity perspective
Interviewee/Contributor
J Fraser Wright
Organisation
Stanford University School of Medicine
A bioethical framework for therapeutic gene editing
Interviewee/Contributor
Janet Lambert
Organisation
Alliance for Regenerative Medicine
The precedents set by Zolgensma
Interviewee/Contributor
Victoria English
Organisation
MedNous
Advanced therapy financing events in Q1 2019
Interviewee/Contributor
Victoria English
Organisation
MedNous
Microsoft pioneers biological computing
Interviewee/Contributor
Victoria English
Organisation
MedNous
Will gene editing unmask synthetic lethal targets?
Interviewee/Contributor
Ceri Wiggins and Jon Moore
Organisation
Horizon Discovery Group Plc
How gene editing is changing the field of medicine
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Producing viral vectors on an industrial scale
Interviewee/Contributor
Nicole Faust
Organisation
CEVEC Pharmaceuticals GmbH
Developing gene therapies: a manufacturing view
Interviewee/Contributor
Madhusudan Peshwa
Organisation
GE Healthcare